Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Eyes and Ocular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05282901
What this trial is testing

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Who this might be right for
Metastatic Uveal Melanoma
Institut Curie 51
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Not applicableWithdrawnNCT02778295
What this trial is testing

Biomarker for Patients With Fabry Disease (BioFabry)

Who this might be right for
AngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more
CENTOGENE GmbH Rostock
Not applicableUnknownNCT03269201
What this trial is testing

Brain Network Activation in Patients With Movement Disorders

Who this might be right for
Parkinson DiseaseEssential TremorDystonia+6 more
Sheba Medical Center 300
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01789320
What this trial is testing

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+2 more
Clearside Biomedical, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Not applicableStudy completedNCT04560790
What this trial is testing

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

Who this might be right for
Viral KeratitisBlindness EyeHerpes Simplex Virus Infection+1 more
Shanghai BDgene Co., Ltd. 3
Early research (Phase 1)Study completedNCT00019344
What this trial is testing

Flavopiridol in Treating Patients With Refractory Cancer

Who this might be right for
LymphomaProstate CancerSmall Intestine Cancer+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableStudy completedNCT00001668
What this trial is testing

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

Who this might be right for
DeafnessKidney DiseasesKidney Neoplasms+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableStudy completedNCT04458935
What this trial is testing

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

Who this might be right for
Retinal HemangioblastomaVon Hippel-Lindau Disease
National Eye Institute (NEI) 25
Large-scale testing (Phase 3)WithdrawnNCT01260103
What this trial is testing

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Who this might be right for
Optic Nerve Glioma
Burzynski Research Institute
Very early researchLooking for participantsNCT07474883
What this trial is testing

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Who this might be right for
Post Inflammtory ErythemaAcne VulgarisErythema
Pham Ngoc Thach University of Medicine 60
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907954
What this trial is testing

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 160
Testing effectiveness (Phase 2)Looking for participantsNCT07281456
What this trial is testing

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

Who this might be right for
Sjogren's Syndrome
National Institute of Dental and Craniofacial Research (NIDCR) 60
Next Page